This Month in Psychopharmacology

TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

The FDA has recently granted clearance of a transcranial magnetic s...

Read More

Stimulants and Sleep Difficulties in Pediatric ADHD

A recent comprehensive study delved into the long-term effects of m...

Read More

CBT Helps Hyperactive Brain Circuits In Pediatric Patients With Anxiety Disorders

A new study reveals that cognitive behavioral therapy (CBT) normali...

Read More

Antipsychotic Medications and Mortality in Children and Young Adults

Children and young adults are commonly prescribed antipsychotics, p...

Read More

STAR-D For Adolescents?

Major depressive disorder (MDD) among adolescents carries high morb...

Read More

Highlights from 2023 NEI Congress: Child and Adolescent Psychiatry Academy

This year’s Child and Adolescent Psychiatry Academy included a seri...

Read More

Childhood Adversity and the Cortisol Awakening Response in Depression

The hypothalamic pituitary adrenal (HPA) axis is the main regulator...

Read More

Stimulant Treatment in Youth Not Associated With Substance Use Later in Life

Childhood attention-deficit/hyperactivity disorder (ADHD) is linked...

Read More

Escitalopram Approved for Generalized Anxiety Disorder in Children

The U.S. Food and Drug Administration has approved escitalopram for...

Read More

Long-Term Safety of Methylphenidate in Children and Adolescents with ADHD

Methylphenidate (MPH) is the most frequently prescribed treatment f...

Read More

Sleep Problems in Childhood & Adolescence Linked to Psychiatric Symptoms

Sleep problems in childhood can increase the risk of developing a p...

Read More

Measures of Brain Connectivity and Cognition by Sex in US Preadolescent Children

Sex differences in brain structure and function may underly differe...

Read More